Laurion Capital Management LP Innoviva, Inc. Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $553,392 - $734,967	-48,163 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$8.11 - $15.23 $390,601 - $733,522	48,163 New	48,163 $566,000
Q3 2018 Nov 13, 2018	SELL	$13.63 - $15.7 $188,121 - $216,691	-13,802 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$13.44 - $17.59 $7,418 - $9,709	-552 Reduced 3.85%	13,802 $190,000
Q1 2018 May 14, 2018	BUY	$13.8 - $16.99 $198,085 - $243,874	14,354 New	14,354 $239,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.